Subscribe Now
You are here : Home / Quarterly Results / CADILA HEALTHCARE LTD

CADILA HEALTHCARE Quarterly Results Analysis Q2FY22 [Sep2021]

Q-o-Q REVENUES OPERATING PROFIT PROFIT AFTER TAX EPS Updated : 29-Oct-21 Details👇

CADILA HEALTHCARE Quarterly Results

Consolidated Sep2021
UnAudited
Jun2021
UnAudited
Mar2021
Audited
Dec2020
UnAudited
Sep2020
UnAudited
Jun2020
UnAudited
Mar2020
Audited
Dec2019
UnAudited
Revenues ₹3,785 Cr ₹4,025 Cr ₹3,847 Cr ₹3,796 Cr ₹3,659 Cr ₹3,515 Cr ₹3,752 Cr ₹3,638 Cr
Expenses ₹2,924 Cr ₹3,092 Cr ₹2,991 Cr ₹2,989 Cr ₹2,845 Cr ₹2,724 Cr ₹2,961 Cr ₹2,940 Cr
Operating Income ₹861 Cr ₹933 Cr ₹855 Cr ₹807 Cr ₹814 Cr ₹791 Cr ₹791 Cr ₹698 Cr
Other Income ₹53 Cr ₹32 Cr ₹-40 Cr ₹28 Cr ₹28 Cr ₹23 Cr ₹44 Cr ₹20 Cr
Interest ₹30 Cr ₹27 Cr ₹23 Cr ₹27 Cr ₹45 Cr ₹68 Cr ₹83 Cr ₹81 Cr
Depreciation ₹185 Cr ₹183 Cr ₹189 Cr ₹180 Cr ₹175 Cr ₹173 Cr ₹179 Cr ₹174 Cr
Profit Before Tax ₹604 Cr ₹755 Cr ₹530 Cr ₹627 Cr ₹490 Cr ₹573 Cr ₹522 Cr ₹457 Cr
Profit After Tax ₹504 Cr ₹613 Cr ₹732 Cr ₹513 Cr ₹390 Cr ₹454 Cr ₹414 Cr ₹364 Cr
EPS ₹29.32 ₹5.73 ₹6.63 ₹5.15 ₹4.62 ₹4.43 ₹3.83 ₹3.65

Check out Industry Peers

Peers & Returns1W1M1Y
CADILA HEALTHCARE -6.7% -13.8% -18.4%
SUN PHARMACEUTICAL INDUSTRIES -3.7% 1.6% 34.6%
DIVIS LABORATORIES -9.6% -9.5% 13.5%
DR REDDYS LABORATORIES -6% -6.9% -13.7%
CIPLA 1% -2.7% 7.1%
GLAND PHARMA -7.8% -12.6% 45.3%
PIRAMAL ENTERPRISES -8.2% -9.4% 48.2%
TORRENT PHARMACEUTICALS -1.2% 0.4% 14%
ALKEM LABORATORIES -1.4% -0.7% 13.5%

CADILA HEALTHCARE Quarterly Revenues

Revenues
Q-o-Q

-5.98 %

Y-o-Y

3.44 %

Quarters Revenues % Change
Sep2021 ₹3,785 Cr
-5.98
Jun2021 ₹4,025 Cr
4.65
Mar2021 ₹3,847 Cr
1.35
Dec2020 ₹3,796 Cr
3.74
Sep2020 ₹3,659 Cr
4.11
Jun2020 ₹3,515 Cr
-6.33
Mar2020 ₹3,752 Cr
3.13
Dec2019 ₹3,638 Cr -

CADILA HEALTHCARE Quarterly Operating Profit

Operating Profit
Q-o-Q

-7.74 %

Y-o-Y

5.78 %

Quarters Operating Profit % Change
Sep2021 ₹861 Cr
-7.74
Jun2021 ₹933 Cr
9.08
Mar2021 ₹855 Cr
6.00
Dec2020 ₹807 Cr
-0.85
Sep2020 ₹814 Cr
2.95
Jun2020 ₹791 Cr
-0.09
Mar2020 ₹791 Cr
13.38
Dec2019 ₹698 Cr -
Operating Margins
Q-o-Q

-1.90 %

Y-o-Y

2.25 %

Quarters Operating Margin% % Change
Sep2021 22.74%
-1.90
Jun2021 23.18%
4.27
Mar2021 22.23%
4.56
Dec2020 21.26%
-4.41
Sep2020 22.24%
-1.11
Jun2020 22.49%
6.64
Mar2020 21.09%
9.96
Dec2019 19.18% -

CADILA HEALTHCARE Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-17.88 %

Y-o-Y

29.27 %

Quarters Profit After Tax % Change
Sep2021 ₹504 Cr
-17.88
Jun2021 ₹613 Cr
-16.20
Mar2021 ₹732 Cr
42.75
Dec2020 ₹513 Cr
31.58
Sep2020 ₹390 Cr
-14.26
Jun2020 ₹454 Cr
9.87
Mar2020 ₹414 Cr
13.47
Dec2019 ₹364 Cr -
PAT Margins
Q-o-Q

-12.67 %

Y-o-Y

24.88 %

Quarters PAT Margin(%) % Change
Sep2021 13.3 %
-12.67
Jun2021 15.23 %
-19.93
Mar2021 19.02 %
40.89
Dec2020 13.5 %
26.76
Sep2020 10.65 %
-17.63
Jun2020 12.93 %
17.33
Mar2020 11.02 %
9.98
Dec2019 10.02 % -

CADILA HEALTHCARE Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

411.69 %

Y-o-Y

534.63 %

Quarters EPS % Change
Sep2021 ₹29.32
411.69
Jun2021 ₹5.73
-13.57
Mar2021 ₹6.63
28.74
Dec2020 ₹5.15
11.47
Sep2020 ₹4.62
4.29
Jun2020 ₹4.43
15.67
Mar2020 ₹3.83
4.93
Dec2019 ₹3.65 -
STOCK RESEARCH & ANALYSIS Smart-Investing
LEARN VIA VIDEO COURSE Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

CADILA HEALTHCARE related INDICES

BSE Indices1W1M1Y
S&P BSE DIVIDEND STABILITY -2% 5.4% 20%
S&P BSE LARGECAP -4.5% 1.6% 19.6%
S&P BSE 100 LARGECAP TMC -4.6% 1.3% 19.7%
S&P BSE LARGE MIDCAP -4.6% 1.3% 20.8%
S&P BSE HEALTHCARE -4.6% -3.5% 9.9%
S&P BSE 200 -4.7% 1.2% 21.5%
S&P BSE 250 LARGEMIDCAP -4.7% 1.1% 22.1%
S&P BSE 500 -4.7% 1.2% 23.7%
S&P BSE ALLCAP -4.8% 1.4% 25%
NSE Indices1W1M1Y
NIFTY 100 EQUAL WEIGHT -3.9% 1% 24.2%
NIFTY PHARMA -4.4% -3% 1.8%
NIFTY HEALTHCARE -4.5% -3.7% NA
NIFTY NEXT 50 -4.6% -1.2% 21.6%
NIFTY 100 -4.6% 1.3% 19.5%
NIFTY 200 -4.7% 1.1% 21.4%
NIFTY 500 -4.8% 1.1% 23.8%
NIFTY LARGE MIDCAP 250 -4.9% 0.6% 27.5%
NIFTY500 MULTICAP 50:25:25 -5% 1.3% 31.8%

You may also like the below Video Courses

Check out Intrinsic Value of Industry Peers
Intrinsic Value of SUN PHARMACEUTICAL INDUSTRIES LTD
Intrinsic Value of DIVIS LABORATORIES LTD
Intrinsic Value of DR REDDYS LABORATORIES LTD
Intrinsic Value of CIPLA LTD
Intrinsic Value of GLAND PHARMA LTD
Intrinsic Value of PIRAMAL ENTERPRISES LTD
Intrinsic Value of CADILA HEALTHCARE LTD
Intrinsic Value of TORRENT PHARMACEUTICALS LTD
Intrinsic Value of ALKEM LABORATORIES LTD
Intrinsic Value of LUPIN LTD
Intrinsic Value of AUROBINDO PHARMA LTD
Intrinsic Value of BIOCON LTD
Intrinsic Value of ABBOTT INDIA LTD
Intrinsic Value of LAURUS LABS LTD
Intrinsic Value of IPCA LABORATORIES LTD
Check out Annual Financials of Industry Peers
Share Price & Financials of SUN PHARMACEUTICAL INDUSTRIES LTD | BOM: 524715 | NSE: SUNPHARMA
Share Price & Financials of DIVIS LABORATORIES LTD | BOM: 532488 | NSE: DIVISLAB
Share Price & Financials of DR REDDYS LABORATORIES LTD | BOM: 500124 | NSE: DRREDDY
Share Price & Financials of CIPLA LTD | BOM: 500087 | NSE: CIPLA
Share Price & Financials of GLAND PHARMA LTD | BOM: 543245 | NSE: GLAND
Share Price & Financials of PIRAMAL ENTERPRISES LTD | BOM: 500302 | NSE: PEL
Share Price & Financials of CADILA HEALTHCARE LTD | BOM: 532321 | NSE: CADILAHC
Share Price & Financials of TORRENT PHARMACEUTICALS LTD | BOM: 500420 | NSE: TORNTPHARM
Share Price & Financials of ALKEM LABORATORIES LTD | BOM: 539523 | NSE: ALKEM
Share Price & Financials of LUPIN LTD | BOM: 500257 | NSE: LUPIN
Share Price & Financials of AUROBINDO PHARMA LTD | BOM: 524804 | NSE: AUROPHARMA
Share Price & Financials of BIOCON LTD | BOM: 532523 | NSE: BIOCON
Share Price & Financials of ABBOTT INDIA LTD | BOM: 500488 | NSE: ABBOTINDIA
Share Price & Financials of LAURUS LABS LTD | BOM: 540222 | NSE: LAURUSLABS
Share Price & Financials of IPCA LABORATORIES LTD | BOM: 524494 | NSE: IPCALAB

Compare Analytics
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of GLAND PHARMA LTD
Market Cap of PIRAMAL ENTERPRISES LTD
Market Cap of CADILA HEALTHCARE LTD
Market Cap of TORRENT PHARMACEUTICALS LTD
Market Cap of ALKEM LABORATORIES LTD
Market Cap of LUPIN LTD
Market Cap of AUROBINDO PHARMA LTD
Market Cap of BIOCON LTD
Market Cap of ABBOTT INDIA LTD
Market Cap of LAURUS LABS LTD
Market Cap of IPCA LABORATORIES LTD

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z